Deka Research and Development
Explore this company’s associated devices, FDA decisions and regulatory history.

Deka Research and Development
- Regulatory records
- 2
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 2 FDA records to the applicant name Deka Research and Development. The collection includes 2 510(k) clearances. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Jun 3, 2026 to Jun 17, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code FPA appears in 1 of the 2 linked filings. The collection spans 2 FDA product codes. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: 340 Commercial St., Manchester, NH, 03101, US. Recorded on K261672, decision dated Jun 17, 2026.
Device categories in this collection
Alternate Controller Enabled Insulin Infusion Pump; Set, Administration, Intravascular.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Regulatory record history
twiist Automated Insulin Delivery (AID) System
K261672 · 510(k) clearanceiiSure Infusion Set
K261530 · 510(k) clearance
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.